[Long term treatment of rheumatoid arthritis with azathioprine and cyclophosphamide].
D000284:Administration, Oral; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D001772:Blood Cell Count; D001797:Blood Protein Electrophoresis; D001799:Blood Sedimentation; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008134:Long-Term Care; D008297:Male; D012217:Rheumatoid Factor / Q000032:analysis
D007136:Immunoglobulins; D003520:Cyclophosphamide; D012217:Rheumatoid Factor; D001379:Azathioprine
Langzeittherapie der Rheumatoiden Arthritis mit Azathioprin und Cyclophosphamid.